1. Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast cancer
Figure 1 | Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast cancer. Underreporting of toxicities is defined as the proportion of patients with self-reported treatment-associated toxicities in any of the treatment cycles that were not reported at all by their physician. Data are from three randomized controlled trials25.
Di. Maio, M. et al. (2016) Patient-reported outcomes in the evaluation of toxicity of anticancer treatments Nat. Rev. Clin. Oncol. doi: /nrclinonc